Name: Patting the Shark: A Surfer's Journey: Learning to Live Well with Cancer (en Inglés)
SKU: 55002960
Price: 469.01 MXN
Availability: InStock
Author: Baker, Tim
ISBN: 9781760898915

portada Patting the Shark: A Surfer's Journey: Learning to Live Well with Cancer (en Inglés)

Patting the Shark: A Surfer's Journey: Learning to Live Well with Cancer (en Inglés)

Formato

Libro Físico

Autor

Tim Baker

Editorial

Ebury Australia

Idioma

Inglés

N° páginas

384

Encuadernación

Tapa Blanda

ISBN13

9781760898915

Categorías

Memorias

Patting the Shark: A Surfer's Journey: Learning to Live Well with Cancer (en Inglés)

Tim Baker (Autor) · Ebury Australia · Tapa Blanda

Libro Nuevo Importado

Envío: 12 a 17 días háb.

$ 938.02$ 469.01

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 2 unidades

$ 469.01

Llega entre el 18 Sep y el 28 Sep a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Patting the Shark: A Surfer's Journey: Learning to Live Well with Cancer (en Inglés)"

A surfer's journey learning to live well with cancer Tim Baker was living the dream. A best-selling and award-winning surf writer with a beautiful family, a lifetime of exotic travel and a home walking distance to quality waves. That all changed on July 7, 2015, when he was diagnosed, out of the blue, with stage 4, metastatic prostate cancer. So began a descent into the debilitating world of aggressive cancer treatments and a fight for a survival as brutal as any big wave hold down. Tim writes candidly and with a raw vulnerability about this perilous journey through chemotherapy, hormone therapy, radiation and surgery, and his own determined lifestyle strategies to maintain mind, body and spirit. Happily, surfing provided one of his most powerful forms of therapy, and writing about his experiences has proven deeply cathartic. In 2020, 1.5 million men were diagnosed with prostate cancer globally and 375,000 lost their lives. In Australia, one in seven men will develop prostate cancer. Yet mainstream oncology concedes its ability to keep men with prostate cancer alive has outstripped its ability to manage the often-devastating side effects of treatment.